
<table style="text-align:center"><caption><strong>EU Market Authorization Counts for Orphan Drugs with Over 1 Market Authorization</strong></caption>
<tr><td colspan="2" style="border-bottom: 1px solid black"></td></tr><tr><td>Trade Name</td><td>Market Authorizations</td></tr>
<tr><td colspan="2" style="border-bottom: 1px solid black"></td></tr><tr><td>Glivec</td><td>6</td></tr>
<tr><td>Nexavar</td><td>3</td></tr>
<tr><td>Revlimid</td><td>3</td></tr>
<tr><td>Carbaglu</td><td>2</td></tr>
<tr><td>Soliris</td><td>2</td></tr>
<tr><td>Torisel</td><td>2</td></tr>
<tr><td>Tracleer</td><td>2</td></tr>
<tr><td>Yondelis</td><td>2</td></tr>
<tr><td>Zavesca</td><td>2</td></tr>
<tr><td colspan="2" style="border-bottom: 1px solid black"></td></tr></table>
